Hawkins (NASDAQ:HWKN) Announces Earnings Results

Hawkins (NASDAQ:HWKN) released its earnings results on Wednesday. The specialty chemicals company reported $0.74 EPS for the quarter, missing the consensus estimate of $0.76 by ($0.02), FiscalAI reports. The firm had revenue of $265.91 million during the quarter, compared to the consensus estimate of $255.28 million. Hawkins had a net margin of 7.75% and a return on equity of 16.85%.

Hawkins Price Performance

Shares of HWKN traded down $6.76 during mid-day trading on Wednesday, reaching $161.83. The company had a trading volume of 210,138 shares, compared to its average volume of 169,644. The company has a market capitalization of $3.38 billion, a price-to-earnings ratio of 40.97, a P/E/G ratio of 3.23 and a beta of 0.81. The company has a debt-to-equity ratio of 0.49, a quick ratio of 1.46 and a current ratio of 2.35. The company’s 50 day simple moving average is $153.61 and its 200 day simple moving average is $146.15. Hawkins has a 1-year low of $115.35 and a 1-year high of $186.15.

Wall Street Analysts Forecast Growth

Several research firms recently issued reports on HWKN. BWS Financial reiterated a “buy” rating and set a $200.00 price target on shares of Hawkins in a research report on Monday, March 23rd. Weiss Ratings restated a “hold (c+)” rating on shares of Hawkins in a research report on Friday, April 10th. One investment analyst has rated the stock with a Buy rating and three have issued a Hold rating to the company. According to MarketBeat.com, Hawkins has a consensus rating of “Hold” and a consensus price target of $200.00.

Hedge Funds Weigh In On Hawkins

Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Wasatch Advisors LP grew its stake in shares of Hawkins by 31.4% during the fourth quarter. Wasatch Advisors LP now owns 552,419 shares of the specialty chemicals company’s stock worth $78,477,000 after buying an additional 131,850 shares during the last quarter. Invesco Ltd. lifted its stake in shares of Hawkins by 44.4% in the 3rd quarter. Invesco Ltd. now owns 407,793 shares of the specialty chemicals company’s stock valued at $74,512,000 after acquiring an additional 125,444 shares during the last quarter. State Street Corp grew its position in Hawkins by 11.6% during the 4th quarter. State Street Corp now owns 1,067,451 shares of the specialty chemicals company’s stock worth $151,642,000 after acquiring an additional 111,318 shares during the last quarter. UBS Group AG increased its holdings in Hawkins by 103.1% in the 3rd quarter. UBS Group AG now owns 49,050 shares of the specialty chemicals company’s stock worth $8,962,000 after purchasing an additional 24,904 shares in the last quarter. Finally, Raymond James Financial Inc. increased its holdings in Hawkins by 32.9% in the 3rd quarter. Raymond James Financial Inc. now owns 96,329 shares of the specialty chemicals company’s stock worth $17,601,000 after purchasing an additional 23,841 shares in the last quarter. Institutional investors own 69.71% of the company’s stock.

About Hawkins

Hawkins, Inc (NASDAQ: HWKN) is a specialty chemical company that produces and distributes water-treatment and industrial chemicals across North America. Founded in 1938 and headquartered in Roseville, Minnesota, the company has built a network of manufacturing facilities and distribution centers that serve municipal, industrial and commercial customers. As a publicly traded entity, Hawkins leverages its long-standing presence in the chemical distribution industry to provide tailored solutions for complex water-treatment challenges and specialty chemical needs.

Hawkins’ product portfolio encompasses a wide range of chemicals, including sodium hypochlorite, sodium hydroxide, hydrogen peroxide, chlorine, acids and specialty blends.